These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Tissue, tear, and serum IgE concentrations in vernal conjunctivitis. Allansmith MR; Hahn GS; Simon MA Am J Ophthalmol; 1976 Apr; 81(4):506-11. PubMed ID: 1266931 [TBL] [Abstract][Full Text] [Related]
32. [Evaluation of the serum level of total immunoglobulins E during allergic-immunological diseases of the eye]. Bloch-Michel E; Cartron JP; Herman D; Campinchi R Arch Ophtalmol Rev Gen Ophtalmol; 1973; 33(8):565-72. PubMed ID: 4272349 [No Abstract] [Full Text] [Related]
33. A double-masked, placebo-controlled evaluation of the efficacy and safety of loteprednol etabonate in the treatment of giant papillary conjunctivitis. The Loteprednol Etabonate Giant Papillary Conjunctivitis Study Group I. Friedlaender MH; Howes J Am J Ophthalmol; 1997 Apr; 123(4):455-64. PubMed ID: 9124242 [TBL] [Abstract][Full Text] [Related]
34. Conjunctival cytologic features in anophthalmic patients wearing an ocular prosthesis. Kim JH; Lee MJ; Choung HK; Kim NJ; Hwang SW; Sung MS; Khwarg SI Ophthalmic Plast Reconstr Surg; 2008; 24(4):290-5. PubMed ID: 18645434 [TBL] [Abstract][Full Text] [Related]
35. Increased numbers of Langerhans cell and expression of HLA-Dr antigen in the giant papilla of patients with giant papillary conjunctivitis. Choi TH; Ko MK; Choe JK Korean J Ophthalmol; 1996 Jun; 10(1):18-23. PubMed ID: 8755197 [TBL] [Abstract][Full Text] [Related]